top of page

Have you struggled to achieve weight loss despite your efforts?

While there are approved treatments and procedures for obesity, they may not be effective for everyone or could cause unwanted side effects. We’re currently recruiting participants for a clinical study investigating the safety and feasibility of Wegovy®, an innovative solution created to support individuals in achieving safe and effective weight loss. If you’re struggling with obesity and interested in a clinical trial which may assist with weight loss, you may be a candidate for this study.

smiling-pretty-woman-typing-on-laptop-working-at-h-2024-10-22-05-26-19-utc.jpg

Overview

Obesity is a long-term health condition defined by an excessive amount of body fat. It is commonly assessed using the body mass index (BMI), where a BMI of 30 or above signifies obesity. This condition is associated with an elevated risk of numerous health issues, such as diabetes, cardiovascular diseases, and some forms of cancer.  The purpose of this study is to measure the effects of Wegovy®, a groundbreaking treatment designed to help individuals lose weight safely and effectively.

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed are key requirements for this clinical trial, but there may be additional requirements to qualify.  

Study Site Location(s)

Tarzana

Huntington Park

​

Inclusion Criteria

  • Male or female participants ≥18 to ≤80 years of age at the time of screening.

  • BMI ≥30 kg/m2, at the screening visit.

  • Non-diabetic individuals

  • No history of weight loss surgeries

  • No recent use of weight loss medications

  • Able to understand and complete study-related questionnaires.

Exclusion Criteria

  • History of Type 1 or Type 2 diabetes  (Gestational Diabetes in permitted)

  • Previous bariatric surgery or planned bariatric surgery

  • Any malignancy in the past 5 years

  • Poorly controlled hypertension

  • Women who are pregnant or breastfeeding

  • Has received any anti-obesity medication within 90 days prior to visit 1

Potential Benefits of Participation

Study staff will determine eligibility based on additional study specific criteria. 

​

  • Participants may be compensated for time and travel

  • No personal insurance is necessary

  • Participants will receive Wegovy and another study medication at no cost 

  • Before and during the study, qualified participants will meet with board-certified physicians and highly-trained and skilled research staff and receive one-on-one care.

​

To get started, register your interest, and our team will contact you.

 

​​

​

Untitled design (2).webp

OFFICIAL

About

​

Valiance Clinical Research combines expertise, agility, and proactive strategies to optimize clinical development and help deliver impactful therapies to patients​

bottom of page